This review focuses on recent studies of HDAC6 in gastrointestinal cancers, including esophageal, gastric, colorectal, liver, and pancreatic cancer, as well as cholangiocarcinoma (CCA). Here, HDAC6 is linked to cholangiocarcinoma.